Prolonged Daily Temozolomide for Low-Grade Glioma

Clinical trial NCT00165360 · COMPLETED

Trial details

NCT number: NCT00165360
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioma Astrocytoma Oligodendroglioma

Start date: 2001-09-01
Primary completion: 2006-12-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.